Céline Schilthuizen, a prominent geriatrician at Rivas Zorggroep in Gorinchem, has been making significant contributions to the field of geriatric care. With a focus on the influence of genetic single nucleotide polymorphisms (SNPs) in elderly patients, Schilthuizen's research has shed light on how genetic variations can impact the efficacy and safety of medications commonly prescribed to older adults.
In her role at Rivas Zorggroep, Schilthuizen has been at the forefront of integrating genetic information into clinical decision-making processes. By analyzing the genetic polymorphisms in key drug-metabolizing enzymes such as CYP3A4 and CYP3A5, Schilthuizen and her team have been able to tailor medication regimens to individual patients, ultimately optimizing treatment outcomes and minimizing the risk of adverse drug reactions.
Schilthuizen's work has not gone unnoticed, with her findings being shared and discussed on various platforms, including Facebook and LinkedIn. Through her posts on LinkedIn, she has been able to engage with a wider audience and foster discussions on the importance of considering genetic factors in geriatric care.
Furthermore, Schilthuizen's research has been recognized and published in reputable sources such as RePub, the Erasmus University Repository. Her studies on the influence of genetic polymorphisms in CYP3A4 and CYP3A5 have added valuable insights to the existing body of knowledge in the field of pharmacogenomics and personalized medicine.
By delving into the intricate relationship between genetics and medication response in elderly patients, Schilthuizen has paved the way for more personalized and effective treatment approaches in geriatric care. Her dedication to advancing the understanding of genetic influences in healthcare has positioned her as a trailblazer in the field of geriatric medicine.
current url：https://siqhiv.e313c.com/all/celine-schilthuizen-28159